期刊文献+

心肌显像剂^(99)Tc^mN-NOET在健康人体中的安全性、生物学分布及内照射辐射吸收剂量 被引量:1

Safety,Biodistribution,and Dosimetry of Myocardial Imaging Agent ^(99)Tc^mN-NOET in Healthy Volunteers
下载PDF
导出
摘要 目的研究心肌显像剂99TcmN-NOET在健康人体中的安全性、生物学分布及内照射辐射吸收剂量。方法10名正常志愿者静脉注射99TcmN-NOET744~792MBq后,观察受试者24h内的生命体征变化及有无不良反应,于给药后1、30min,1、2、4、8和24h进行全身显像以测定生物分布,用感兴趣区技术对重要器官进行放射性计数,用MIR-DOSE3.0剂量估算软件,估算各主要受照器官的内照射辐射吸收剂量。于给药后1和4h进行心肌断层显像。结果试验后24h内受试者的生命体征如心率、血压和心电图无明显变化,无任何不良反应。所有受试者的血清学和生化指标均无改变。心肌对99TcmN-NOET的摄取较高,2h时达2.68%;给药后30min心/肺比值大于1,2h达最大,为1.91±0.53。有效剂量当量为1.28×10-5Sv/MBq,按一次给药740MBq计算,各主要器官的内照射辐射吸收剂量均低于50mGy。结论心肌对99TcmN-NOET的摄取率高,断层图像清晰,99TcmN-NOET的内照射辐射吸收剂量低,安全性好,符合临床用放射性显像剂的要求。 Objective To study the safety, biodistribution, and dosimetry of myocardial perfusion imaging agent ^(99)Tc^mN-NOET in 10 healthy volunteers. Methods 744-792 MBq of ^(99)Tc^mN-NOET was injected to each volunteer. Safety parameters and adverse event was measured in 24 hours of injection. Biodistribution was studied by whole-body imaging 1, 30 minutes, 1, 2, 4, 8, and 24 hours after the injection of ^(99)Tc^mN-NOET. The estimation of dosimetry was based on the standard medical internal radiation dose method using MIRDOSE 3.0 analysis program. Myocardial single photon emission computed tomography (SPECT) imaging was performed at 1 and 4 hours after injection. Results No undesirable effects were reported by the subject during 24 hours after injection of ^(99)Tc^mN-NOET . No clinically significant changes were found in vital signs (heart rate, blood pressure, and electrocardiogram). No biochemical aspects and serology changes were measured. The myocardial SPECT imaging was clear. Cardiac uptake of ^(99)Tc^mN-NOET was as high as 2.68% at 2 hours after injection. The heart to lung ratio was more than 1 from 30 minutes after injection, reaching a maxi- mum of 1.91 ± 0.53 at 2 hours after injection. Radiation dosimetry calculations indicated an effective absorbed dose of 1.28 ×10^-5 Sv/MBq. The dosimetry in each main organ is lower then 50mGy given 740 MBq of ^(99)Tc^mN-NOET in once imaging. Conclusions effective absorbed dose. It's a safe myocardial ^(99)Tc^mN-NOET exhibits high cardiac uptake and low estimated perfusion imaging agent.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2007年第4期517-521,共5页 Acta Academiae Medicinae Sinicae
关键词 99TcmN-NOET 心肌灌注显像 生物分布 吸收剂量 ^(99)Tc^mN-NOET myocardial perfusion imaging biodistribution dosimetry
  • 相关文献

参考文献8

二级参考文献21

  • 1田月琴,王金城,何作祥,王蒨,胡奉环,杨伟宪,王琦,戴皓洁,姚稚明.腺苷负荷试验心肌灌注显像诊断冠心病的临床价值[J].中华心血管病杂志,2005,33(1):58-61. 被引量:81
  • 2李大元,汪丽葱,朱国英,张钧华,高炜,霍勇,冯大力,吴树燕.心电图运动试验对判断经皮冠状动脉腔内成形术后再狭窄的意义[J].中华心血管病杂志,1995,23(6):411-413. 被引量:18
  • 3范中杰,陈黎波,李方,沈珠军,张抒扬,严晓伟,刘震宇,张德利,方全.冠状动脉介入治疗前后腺苷负荷心肌核素显像的临床意义[J].中华心血管病杂志,2005,33(11):1023-1026. 被引量:5
  • 4Jeetley P,Sabharwal NK,Soman P,et al.Comparison between Tc-^99mN-NOET and T1-201 in the assessment of patients with known or suspected coronary artery disease.J Nucl Cardiol,2004,11:664-672.
  • 5Takehana K,Beller GA,Ruiz M,et al.Assessment of residual coronary stenoses using ^99Tc^m-N-NOET vasodilator stress imaging to evaluate coronary flow reserve early after coronary reperfusion in a canine model of subendocardial infarction.J Nucl Med,2001,42:1388-1394.
  • 6Riou L,Ghezzi C,Pasqualini R,et al.Influence of calcium channel inhibitors on the myocardial uptake and retention of technetium ^99m N-NOET,a new myocardial perfusion imaging agent:a study on isolated perfused rat hearts.J Nucl Cardiol,2000,7:365-372.
  • 7Rodgers GP,Ayanian JZ,Balady G,et al.American college of cardiology/american heart association clinical competence statement on stress testing:a report of the american college of cardiology/american heart association/american college of physicians-american society of internal medicine task force on clinical competence.Circulation,2000,102:1726-1738.
  • 8Klocke FJ,Baird MG,Lorell BH,et al.ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.J Am Coil Cardiol,2003,42:1318-1333.
  • 9Dem aim ay F,Dazord L,Roucoux A,et al.Rhenium-188and technetium - 99m nitridobis (N- ethoxy- N-ethyldithiocarbamate) leucocyte labelling radiopharm a-ceuticals:[188Re N (NOET) 2 ]and[99m Tc N (NOET)2 ],NOET=Et(Et O) NCS2 :their in vitro localizationand chemical behaviour[].Nuclear Medicine and Biology.1997
  • 10Dem aim ay F,Dazord L,Roucoux A,et al.Rhenium-188and technetium - 99m nitridobis (N- ethoxy- N-ethyldithiocarbamate) leucocyte labelling radiopharm a-ceuticals:[188Re N (NOET) 2 ]and[99m Tc N (NOET)2 ],NOET=Et(Et O) NCS2 :their in vitro localizationand chemical behaviour[].Nuclear Medicine and Biology.1997

共引文献8

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部